Back to Trades
LYONS GARY A
DirectorCIK 0001123343
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 10
- Companies
- 2
- Active
- 2026
LYONS GARY A, Director, has filed 5 SEC reports (2026), spread across 2 companies, totaling $6.1M in disclosed volume. Weighing $0 bought versus $3.4M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Nov 19 | NBIX NEUROCRINE BIOSCIENCES INC | LYONS GARY A | Director | Sell | $2.5M |
| Aug 19 | TVTX Travere Therapeutics, Inc. | LYONS GARY A | Insider | Sell | $632.8K |
| May 29 | NBIX NEUROCRINE BIOSCIENCES INC | LYONS GARY A | Director | Award | $408.9K |
| May 21 | NBIX NEUROCRINE BIOSCIENCES INC | LYONS GARY A | Director | Exercise | $0 |
| Apr 16 | TVTX Travere Therapeutics, Inc. | LYONS GARY A | Insider | Sell | $328.6K |
5 filings